Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations.

Gynecologic oncology - 1 Oct 2024

Polan Rosa M, Ali-Fehmi Rouba, Grace Anne K, Mattei Larissa H, Tanner Edward J, Morris Robert T

Abstract excerpt

OBJECTIVE: To describe extension of ovarian tissue beyond visible and National Comprehensive Cancer Network recommended margins among patients with BRCA mutations undergoing minimally invasive risk-reducing salpingo-oophorectomy. METHODS: A prospective study of patients with BRCA mutations who underwent minimally invasive risk-reducing bilateral salpingo-oophorectomy was conducted. Patient enrollment occurred...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA2 Protein
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Mutation

Share to Ovarian Neoplasms

Share to Salpingo-oophorectomy

Source

Identifiers

PMID: 39003959
DOI: 10.1016/j.ygyno.2024.07.005

Genes

BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations.PMID 39003959Read ↗

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.Semantic proximity Read ↗

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.Semantic proximity Read ↗

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Semantic proximity Read ↗

Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers : A Case Series.Semantic proximity Read ↗

Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience.Semantic proximity Read ↗

Factors affecting the diagnostic discordance between frozen and permanent sections in mucinous ovarian tumorsSemantic proximity Read ↗

Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).Semantic proximity Read ↗

Ovarian tissue cryopreservation: benefits and risksSemantic proximity Read ↗

Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.Semantic proximity Read ↗

Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.